This website uses cookies
More information
Site Filter — Worldwide / All Aircraft
Pilot medical certificate to remain valid post-vaccine
The FAA has authorised pilots to receive the Pfizer COVID-19 vaccine, administered in two doses over a 21-day period, without compromising the validity of their pilot medical certificates. NBAA welcomes the news.

The NBAA has welcomed prompt action by FAA administrator Steve Dickson and acting Federal Air Surgeon Dr. Brett Wyrick to ensure pilots may be vaccinated against COVID-19 without risk to their medical certificate.

The Federal Drug Administration (FDA) issued emergency-use authorisation for Pfizer's COVID-19 vaccine on 11 December. In an order issued the next morning, the FAA authorised pilots to receive the Pfizer vaccine, administered in two doses over a 21-day period, without compromising the validity of their pilot medical certificates.

Without such an order, pilots receiving vaccines that have not received full FDA approval risk invalidating their certificate. The order also applies to air traffic control personnel, who are also subject to FAA medical clearance requirements.

“We are grateful to the FAA for taking this immediate and proactive step to address medical certification concerns related to COVID-19 vaccinations that will aid in keeping the aviation industry moving forward,” says NBAA president and CEO Ed Bolen. “Administrator Dickson's previous military and civilian aviation experience continues to offer him unique insights on pilot-focused challenges, which in this case have proven astute, and we thank him and his team for their foresight and action on this matter.”

The FAA order requires that pilots must refrain from flying for 48 hours after receiving each dose of the Pfizer vaccine, after which time they may return to duty. Similar mandatory waiting periods are in place for those receiving other vaccines, the FAA noted, including against tuberculosis and typhoid.

While the agency “anticipates taking no additional measures to ensure safety after the initial window for side effects closes,” the FAA emphasised its medical professionals “will continuously monitor the initial distribution of the novel vaccine and documented clinical results and will adjust these recommendations as needed.”

Co-developed with Germany's BioNTech, the Pfizer vaccine is the first COVID-19 vaccine to receive authorisation in the US, with a second vaccine from Moderna currently under FDA review. Initial clinical trials have shown both vaccines to be highly effective against the virus.

Other News
 
EU Summit lays out plans for sustainable fuels
April 25, 2021
The largest potential reduction in aviation's green house gas emissions, and key to reaching goals to reduce them, will come about through the broad adoption of SAF, according to the EU's private aviation SAF Summit.
NBAA and AOPA express GPS jamming concerns
March 15, 2021
Stimulus package welcomed by NBAA and NATA
March 15, 2021
Under a new bill passed by the US Senate, the Payroll Support Program (PSP) for air carriers and general aviation commercial operators would receive $14 billion, plus another $1 billion for qualifying contractors.
Dickson to impart wisdom at NBAA virtual event
February 22, 2021
Unchartered waters force show cancellations
February 8, 2021
Although vaccination programmes are ramping up, there is a long road ahead in Europe for travel to be safe. With this in mind, EBAA and NBAA have decided that EBACE2021 cannot go ahead in its traditional format.
NBAA applauds IRS role in clarifying tax obligations
January 15, 2021